Title: Lorcainide
CAS Registry Number: 59729-31-6
CAS Name: N-(4-Chlorophenyl)-N-[1-(1-methylethyl)-4-piperidinyl]benzeneacetamide
Additional Names: 4¢-chloro-N-(1-isopropyl-4-piperidyl)-2-phenylacetanilide
Molecular Formula: C22H27ClN2O
Molecular Weight: 370.92
Percent Composition: C 71.24%, H 7.34%, Cl 9.56%, N 7.55%, O 4.31%
Literature References: Prepn: S. Sanczuk, H. K. F. Hermans, DE 2642856 (1977 to Janssen), C.A. 87, 53094 (1977); eidem, US 4126689 (1978 to Janssen). Determn of lorcainide and its metabolites by GLC: R. Woestenborghs et al., J. Chromatogr. 164, 169 (1979). Disposition and anti-arrhythmic effects: U. Klotz et al., Int. J. Clin. Pharmacol. Biopharm. 17, 152 (1979). Pharmacokinetics and tissue distribution: U. Klotz, E. Golbs, Arzneim.-Forsch. 30, 619 (1980). Clinical study: P. Somani, S. di Giorgi, Chest 78, 658 (1980). Toxicology: G. J. Barton, R. Marsboom, "A Brief Summary of Animal Toxicology Studies on Lorcainide", in Prognosis and Pharmacotherapy of Life-Threatening Arrhythmias, Jähnchen et al., Eds. (Royal Soc. Med. London, 1981) pp 23-25. Review of pharmacology and efficacy: C. E. Eriksson, R. N. Brogden, Drugs 27, 279-300 (1984). Symposium: Am. J. Cardiol. 54, 1B-54B (1984).
Properties: LD50 in male mice, male and female rats (mg/kg): 18.8, 19.3, 18.6 i.v.; 483, 395, 435 orally (Barton, Marsboom).
Toxicity data: LD50 in male mice, male and female rats (mg/kg): 18.8, 19.3, 18.6 i.v.; 483, 395, 435 orally (Barton, Marsboom)
Derivative Type: Hydrochloride
CAS Registry Number: 58934-46-6
Manufacturers' Codes: R-15889; Ro-13-1042
Trademarks: Lopantrol (Janssen); Lorivox (Srbolek); Remivox (Janssen)
Molecular Formula: C22H27ClN2O.HCl
Molecular Weight: 407.38
Percent Composition: C 64.86%, H 6.93%, Cl 17.41%, N 6.88%, O 3.93%
Properties: Crystals from 2-propanone and 2-propanol, mp 263°.
Melting point: mp 263°
Therap-Cat: Antiarrhythmic (class IC).
Keywords: Antiarrhythmic. |